Demand for Fillers on the Rise: FDA Reviews Safety Issues
Posted November 30, 2008 in Injection Treatments
On November 18, Food and Drug Administration officials will meet with a panel of outside experts to discuss possible changes in the labeling of cosmetic dermal fillers like Juvederm, Restylane, Radiesse and others that continue to flood the market. Within the last six years, the FDA has received 930 reports about complications related to injectable […]
Read More